Price Gouging or “Too Aggressive”
Valeant CEO J. Michael Pearson told the Senate Special Committee on Aging on Wednesday he and the company “made mistakes”
Read MoreValeant CEO J. Michael Pearson told the Senate Special Committee on Aging on Wednesday he and the company “made mistakes”
Read More(By Jordan Rau for Kaiser Health News) When Democrats fault the Affordable Care Act, it’s increasingly because it does not
Read More(By Anna Gorman for Kaiser Health News) VAN NUYS, Calif. — Andy Martin’s body had rejected another HIV medication, and
Read MoreFrom 1965 to 1970, U.S service members (2.6 million) were potentially exposed to Agent Orange, which contained a dangerous strand
Read MoreWhen we talk about recycling old drugs we are talking about finding new uses for existing medications. The famous two
Read MorePfizer best- selling product is not Viagra, Lipitor, or Lyrica but Prevnar a vaccine. In 2015, Prevnar revenues were $6.25
Read More(By Sandra G. Boodman for Kaiser Health News) After James Happli of Mosinee, Wisconsin, was diagnosed with pancreatic cancer, he
Read MoreThe Centers for Medicare & Medicaid Services (CMS) released a proposed rule that will change the Medicare reimbursement policies at
Read MoreIn a 7 – 3 vote, a panel of Food and Drug Administration experts voted against the experimental treatment drug
Read MoreIn Western Pennsylvania, recently more retirees are choosing traditional Medicare plan with a Medigap supplement instead of Medicare Advantage plans.
Read More